Presentation is loading. Please wait.

Presentation is loading. Please wait.

Activation of integrin receptors is required for growth factor–induced smooth muscle cell dysfunction  Kyotaro Mawatari, MD, Bo Liu, PhD, K.Craig Kent,

Published byΖηνοβία Ηλιόπουλος Modified over 5 years ago

Similar presentations

Presentation on theme: "Activation of integrin receptors is required for growth factor–induced smooth muscle cell dysfunction  Kyotaro Mawatari, MD, Bo Liu, PhD, K.Craig Kent,"— Presentation transcript:

1 Activation of integrin receptors is required for growth factor–induced smooth muscle cell dysfunction  Kyotaro Mawatari, MD, Bo Liu, PhD, K.Craig Kent, MD  Journal of Vascular Surgery  Volume 31, Issue 2, Pages (February 2000) DOI: /S (00) Copyright © 2000 Society of Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2 Fig. 1 Effect of inhibitory integrin antibodies on SMC DNA synthesis induced by PDGF-BB. DNA synthesis (24 hours) as measured by 3H-thymidine incorporation following stimulation of quiescent vascular SMCs with PDGF-BB (5 ng/mL) in the presence of antibodies to αvβ3, α2β1, α2, β1, and IgG control (dilutions 1:100). Results are expressed as percent of IgG control ± SD. Experiments were performed in triplicate and repeated three times with use of separate cell cultures. Data from a representative example are shown (*P <.05 compared with control). Journal of Vascular Surgery  , DOI: ( /S (00) ) Copyright © 2000 Society of Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

3 Fig. 2 Effect of inhibitory integrin antibodies on SMC DNA synthesis induced by EGF. DNA synthesis (24 hours) as measured by 3H-thymidine incorporation following stimulation of quiescent vascular SMCs with EGF (20 ng/mL) in the presense of antibodies to αvβ3, α2β1, α2, β1, and IgG control (dilutions 1:100). Results are expressed as percent of IgG control ± SD. Experiments were performed in triplicate and repeated three times with use of separate cell cultures. Data from a representative example are shown (*P <.05 compared with control). Journal of Vascular Surgery  , DOI: ( /S (00) ) Copyright © 2000 Society of Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

4 Fig. 3 Effect of inhibitory integrin antibodies on SMC DNA synthesis induced by bFGF. DNA synthesis (24 hours) as measured by 3H-thymidine incorporation following stimulation of quiescent vascular SMCs with bFGF (20 ng/mL) in the presense of antibodies to αvβ3, α2β1, α2, β1, and IgG control (dilutions 1:100). Results are expressed as percent of IgG control ± SD. Experiments were performed in triplicate and repeated three times with use of separate cell cultures. Data from a representative example are shown (*P <.05 compared with control). Journal of Vascular Surgery  , DOI: ( /S (00) ) Copyright © 2000 Society of Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

5 Fig. 4 Effect of inhibitory integrin antibodies on SMC fibronectin production induced by TGF-β and EGF. Fibronectin production as measured by Western blotting following 72 hours stimulation of quiescent vascular SMCs with TGF-β (20 ng/mL) (upper panel) and EGF (100 ng/mL) (lower panel) in the presence of antibodies to αvβ3, α2β1, α2, β1, and IgG control (dilutions 1:100). Fn was assayed in the cell medium with use of an antibody specific for the 220-kDa subunit. All experiments were repeated three times with cells from three separate cultures. Data from a representative example are shown. Journal of Vascular Surgery  , DOI: ( /S (00) ) Copyright © 2000 Society of Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Download ppt "Activation of integrin receptors is required for growth factor–induced smooth muscle cell dysfunction  Kyotaro Mawatari, MD, Bo Liu, PhD, K.Craig Kent,"

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,
The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.
The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.
Graft smooth muscle cells specifically synthesize increased collagen

Graft smooth muscle cells specifically synthesize increased collagen
Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies?  John G. Adams, MD, Loren J. Humphrey, MD, PhD, Xinchao.

Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies?  John G. Adams, MD, Loren J. Humphrey, MD, PhD, Xinchao.
Peter R. Nelson, MD, Shinji Yamamura, MD, K.Craig Kent, MD 

Peter R. Nelson, MD, Shinji Yamamura, MD, K.Craig Kent, MD 
Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells  Ulf Hedin, MD, PhD, Günter Daum, PhD, Alexander.

Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells  Ulf Hedin, MD, PhD, Günter Daum, PhD, Alexander.
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 
Patrick C. H. Hsieh, MD, Richard D. Kenagy, PhD, Eileen R

Patrick C. H. Hsieh, MD, Richard D. Kenagy, PhD, Eileen R
Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R

Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R
Robert J. Pitsch, MD, David J. Minion, MD, Margaret L

Robert J. Pitsch, MD, David J. Minion, MD, Margaret L
Folic acid inhibits homocysteine-induced proliferation of human arterial smooth muscle cells  Brennan J. Carmody, MD, Subodh Arora, MD, Ricardo Avena,

Folic acid inhibits homocysteine-induced proliferation of human arterial smooth muscle cells  Brennan J. Carmody, MD, Subodh Arora, MD, Ricardo Avena,
Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1α  Alan Dardik,

Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1α  Alan Dardik,
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 

The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 
Jian-ming Li, MDa, Charles S. C. Garnette, MDa, Mitchell Cahn, MDa, R

Jian-ming Li, MDa, Charles S. C. Garnette, MDa, Mitchell Cahn, MDa, R
Peter R. Nelson, MD, Shinji Yamamura, MD, K.Craig Kent, MD 

Peter R. Nelson, MD, Shinji Yamamura, MD, K.Craig Kent, MD 
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.

Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.
Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R

Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R
A new valvulotome for in situ bypass grafts

A new valvulotome for in situ bypass grafts
Nicholas P. Ziats, PhD, James M. Anderson, MD, PhD 

Nicholas P. Ziats, PhD, James M. Anderson, MD, PhD 

Similar presentations

Ads by Google